Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Chimia (Aarau) 2019, 73, 185193
BPC-157 also enhances growth hormone receptor expression in fibroblasts and promotes FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival during tissue repair processes
44 To create GFOGER-modified hydrogels, the collagen mimetic peptide containing GFOGER, with the sequence (GPO)4GFOGER(GPO)4GCG(CMP), is chemically integrated into PEG hydrogels through Michael addition chemistry, thereby facilitating the functionalization of PEG